The Microneedling Market size was valued at USD 0.46 billion in 2022 and is projected to grow from USD 0.51 Billion in 2023 to USD 1.01 billion by 2030, exhibiting a compound annual growth rate (CAGR) of 10.31% during the forecast period (2024 - 2030). The increase in demand for minimally invasive procedures, the rise in usage of microneedling, and the growing medical tourism industry are driving the market growth.
Source: Secondary Research, Primary Research, MRFR Database, and Analyst Review
Demand for minimally and non-invasive skin rejuvenation and body contouring procedures using novel radiofrequency systems is growing at a rapid pace. These minimally and non-invasive technologies have become the fastest-growing areas of aesthetic medicine. Microneedling is a minimally invasive, non-ablative technique commonly used for body contouring, skin tightening, and cellulite reduction.
Moreover, electromagnetic technology is based on the use of an oscillating electrical current that generates and delivers thermal energy to the deep dermis and subcutaneous fat that stimulates the production of collagen, elastin, and hyaluronic acid, resulting in skin tightening and lifting, while causing minimal damage to superficial structures of the skin. For instance, in February 2020, US Food and Drug Administration has approved Lutronic’s (US) genius microneedling platform or radiofrequency microneedling. Lutronic genius microneedling platform is a minimally invasive cosmetic treatment used to reduce the appearance of wrinkles, scarring, and sagging skin. As a result, the microneedling market is expected to be driven by an increase in demand for minimally invasive procedures.
The biggest benefit of medical travel is the cost savings because facilities in underdeveloped nations can charge less because of the country's economic situation.
In undeveloped countries, there is a lower gross domestic product (GDP) per capita, which translates to lower incomes. Additionally, costs for medical procedures and treatments are far lower than in wealthy countries. Using US prices as a comparison, the average cost savings for the most popular locations in the year 2022 are shown in the below figure.
The Market segments of Microneedling, based on procedure, includes RF microneedling, traditional microneedling, and PRP microneedling. The RF microneedling segment held the majority share in 2022 in the Microneedling Market revenue. This is due to increasing demand for non-surgical and minimally invasive cosmetic treatments that produce visible results with minimal downtime. Moreover, a study published by the National Center for Biotechnology Information (NCBI) in 2018 aimed to evaluate the safety and effectiveness of automated microneedling devices for facial rejuvenation. Also, they reported that non-surgical treatments that eliminate fat and tighten skin increased by nearly 20% over the previous year.
February 2020 Cynosure (US) launched a new product Potenza radiofrequency (RF) microneedling device. This is the only US FDA approved four mode RF microneedling device which provides clinicians unique versatility and distinguished treatments for patients.
The Market segmentation of Microneedling, based on the product, includes derma-stamp, dermapen, dermarollers, RF microneedling devices, and others. The RF microneedling devices segment held the majority share in 2022 in the market revenue of Microneedling. This is due to the higher efficiency of RF microneedling compared to traditional microneedling devices and the growing demand for non-invasive cosmetic procedures.
The Microneedling Market segmentation, based on needle material, includes silicon, metal, glass, and others. The silicon segment held the majority share in 2022 of the Market revenue of Microneedling. This is due to advancements in silicon-based microneedles technology, and the rising prevalence of skin diseases and conditions. Also, Silicon needles can also be designed to have a range of shapes and sizes, allowing them to be tailored to specific applications such as drug delivery or facial rejuvenation. Furthermore, researchers continue to explore the potential of silicon needles for new applications, such as the delivery of gene therapies or the treatment of skin diseases.
The Market segmentation of Microneedling is based on an application that includes, skin rejuvenation, acne scars, traumatic & surgical scars, and others. The skin rejuvenation segment has dominated the market in 2022 and the acne scars segment is projected to be the fastest-growing during the forecast period, 2023–2030. This is attributed to the growing demand for minimally invasive cosmetic procedures and the increasing prevalence of skin conditions such as aging and sun damage. According to The International Society of Aesthetic Plastic Surgery (ISAPS), facial rejuvenation procedures are among the most frequently carried out minimally aesthetic procedures globally, with a significant number of procedures being carried out in the U.S. alone. Furthermore, this highlights the growing demand for aesthetic procedures, including skin rejuvenation, and is expected to continue to drive market growth.
Figure 2: MICRONEEDLING MARKET, BY APPLICATION, 2023 & 2030 (USD Billion)
Source: Secondary Research, Primary Research, MRFR Database, and Analyst Review
The Microneedling Market segmentation is based on end-user that includes hospitals, dermatology clinics, home care settings, and others. The hospitals segment has dominated the market in 2022 and the homecare settings segment is projected to be the fastest-growing during the forecast period, 2023–2030. This is due to the growing incidence of skin-related conditions and the rising number of hospitals and clinics. In addition, hospitals have access to advanced equipment and skilled medical professionals, making them a preferred choice for patients seeking microneedling procedures. Furthermore, the increasing number of hospitals offering cosmetic procedures and the growing demand for minimally invasive treatments are expected to further drive the growth of the hospital’s segment in the market of microneedling.
February 2020 The US FDA has approved Lutronic’s (US) Genius RF Microneedling Platform or radiofrequency microneedling. Lutronic Genius RF microneedling platform is a minimally invasive cosmetic treatment used to reduce the appearance of wrinkles, scarring, and sagging skin.
By Region, the study segments the market into North America, Europe, Asia-Pacific, and the Rest of the World. The North American microneedling market accounted for the largest market share in 2022. This is due to the increasing incidence of alopecia and different dermatological diseases and the presence of advanced healthcare facilities and skilled professionals in the region, and the rising strategic partnership and increasing investment by major players in the region.
Further, increasing technological advancement and rising awareness about microneedling procedures in the region are expected to further drive the growth of the regional segment in the market of microneedling. Further, the major countries studied are the U.S., Canada, Germany, France, the UK, Italy, Spain, China, Japan, India, Australia, South Korea, and Brazil.
Figure 3: MICRONEEDLING MARKET BY REGION 2023 & 2030
Source: Secondary Research, Primary Research, MRFR Database, and Analyst Review
Europe microneedling market accounts for the second-largest market share due to the growing support by government bodies for the use of minimally invasive procedures, the increasing number of product approvals and the availability of products across the region, and the growing popularity of minimally invasive technology in the region. furthermore, the Germany market of microneedling was attributed to holding the largest market share, and the UK market of microneedling is expected to fastest-growing market in the European region.
The Asia-Pacific microneedling market is expected to grow at a significant share from 2023 to 2030. This is due to the increase in the demand for antiaging treatment, the rise in the standard of living, and the growing R&D activities in surgical procedures in the Asia-Pacific region. Moreover, Japan market of microneedling is expected to hold the largest market share, and India market of microneedling is expected fastest-growing market in the Asia-Pacific region.
Furthermore, the growing consumer disposable income levels in emerging countries and growing technological innovation are likely to have considerable market growth for the microneedling.
The Rest of the World is segmented into the Middle East, Africa, and Latin America. The market for microneedling in the above-mentioned regions is likely to witness growth due to the rising prevalence of minimally-invasive procedures and the rising aesthetic consciousness among consumers in these regions. Moreover, increasing healthcare expenditure and the growing awareness of microneedling procedures are expected to propel the microneedling market growth in the region.
Microneedling Key Market Players & Competitive Insights
The Microneedling Market is characterized by the presence of many global, regional, and local vendors catering to the demand created by research scientists and pharmaceutical and biotechnology companies operating in the industry. The market comprises tier-1, tier-2, and local players. The tier-1 and tier-2 players have reach across the globe with diverse product portfolios. Companies such as Crown Aesthetics (US), Lumenis Be Ltd (Israel), Aesthetics Biomedical (US), and INMODE (US) dominate the market of Microneedling due to product differentiation, financial stability, strategic developments, and diversified regional presence.
The players are focused on investing in research and development. Furthermore, they adopt strategic growth initiatives, such as expansion, product launches, joint ventures, and partnerships, to strengthen their market position and capture a large customer base. One of the primary business strategies adopted by manufacturers in the global microneedling industry to benefit clients and expand the microneedling market sector is to manufacture locally to reduce operating costs.
Crown Aesthetics (US) is a manufacturer of premier medical aesthetics equipment. It offers products such as SkinPen, the first FDA-cleared microneedling device, MicroPen EVO, Platelet-rich Plasma (PRP) systems ProGen PRP Advantage and Eclipse PRP, VOTESSE, a hair health system; and the post-micro needling protocol Skinfuse. Crown has excelled in dermatology and aesthetics due to its unwavering pursuit of therapeutic excellence and improved patient results. It has a strong presence in the US, and it distributes products in over 41 countries.
Furthermore, the company operates in North America, Europe, Asia, Oceania, Africa, and the Middle East. For instance, in February 2023, Crown Aesthetics (US) launched the SkinPen Premium Biocellulose Masque microneedling device for post-treatment skin soothing. This new addition to the SkinPen Precision Treatment Kits marks the first premium upgrade to the Treatment Kit options from Crown Aesthetics.
Also, Lumenis Be Ltd (Israel) is a manufacturer and distributor of minimally invasive clinical devices, medical and aesthetic lasers, and light-based systems. The company offers holmium lasers, CO2 lasers, reusable fibers, multi-wavelength lasers, laser photocoagulators, and other aesthetic devices. In addition, the company offers its solutions to a variety of medical environments, including aesthetic, and ophthalmic procedures. It has an operational presence in the Americas, Europe, the Middle East, and Asia-Pacific. Furthermore, it has operations in the US, China, Japan, India, Germany, and Australia.
Key Companies in the market of Microneedling include
Microneedling Industry Developments
October 2022 The US Food and Drug Administration (FDA) has approved Aesthetics Biomedical’s (US) Vivace Ultra RF Microneedle. The RF microneedling device Vivace Ultra offers the widest range of frequency possibilities, as well as insulated and non-insulated needle sets for both larger and smaller, more accurate areas.
July 2021 Crown Aesthetics (US) launched MicroPen EVO Advanced Microneedling Device in Canada. MicroPen EVO microneedling can be used to treat acne scars and slow the signs of ageing.
June 2021 Cutera (US) launched its new product Secret PRO for the treatment of skin rejuvenation, utilize CO2 skin rematerializing application “Ultra Light” to target the epidermis, whereas simultaneously utilizing the Secret RF microneedling technology to spread the subdermal layers of the skin. With this product launch, the company expanded their product portfolio as well as strengthen their business.
September 2020 INMODE (US) launched Morpheus8, a radiofrequency device with combined microneedling. It is designed for use on the face and body. The device is useful for both the superficial and subcutaneous fatty layers of the skin, giving users instant effects as well as more even, symmetrical, durable, and consistent results.
© 2024 Market Research Future ® (Part of WantStats Reasearch And Media Pvt. Ltd.)